A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
出版年份 2020 全文链接
标题
A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo
作者
关键词
Nuciferine, Multidrug resistance, Multiple-targets, PI3K/AKT/ Nrf2/ HIF-1α, P-gp, BCRP
出版物
PHYTOMEDICINE
Volume 79, Issue -, Pages 153342
出版商
Elsevier BV
发表日期
2020-09-10
DOI
10.1016/j.phymed.2020.153342
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
- (2020) Lei Zhang et al. Molecular Cancer
- Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases—Current State of the Art
- (2020) Karina Smorodinsky-Atias et al. Cells
- Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway
- (2019) Zizhuo Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nuciferine alleviates acute alcohol-induced liver injury in mice: Roles of suppressing hepatic oxidative stress and inflammation via modulating miR-144/Nrf2/HO-1 cascade
- (2019) Guangwen Shu et al. Journal of Functional Foods
- Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: Total synthesis and discovery of potent MDR reversal agents
- (2019) Senling Feng et al. Acta Pharmaceutica Sinica B
- YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine
- (2019) Ling Zhou et al. Biomolecules
- Nrf2/P–glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer
- (2018) Mohammad Reza Sadeghi et al. BIOMEDICINE & PHARMACOTHERAPY
- NRF2 and the Hallmarks of Cancer
- (2018) Montserrat Rojo de la Vega et al. CANCER CELL
- Nuciferine alleviates LPS-induced mastitis in mice via suppressing the TLR4-NF-κB signaling pathway
- (2018) Xingxing Chen et al. INFLAMMATION RESEARCH
- Nuciferine Inhibits Proinflammatory Cytokines via the PPARs in LPS-Induced RAW264.7 Cells
- (2018) Chao Zhang et al. MOLECULES
- The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment
- (2017) Violetta Krajka-Kuźniak et al. Pharmacological Reports
- Hypoxia regulates ABCG2activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells
- (2016) Xiaodan He et al. CANCER BIOLOGY & THERAPY
- HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway
- (2016) Hong Wang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Salvianolic acid B reverses multidrug resistance in HCT-8/VCR human colorectal cancer cells by increasing ROS levels
- (2016) Piaoting Guo et al. Molecular Medicine Reports
- Long-Term Alteration of Reactive Oxygen Species Led to Multidrug Resistance in MCF-7 Cells
- (2016) Juan Cen et al. Oxidative Medicine and Cellular Longevity
- New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
- (2015) Jelena Dinic et al. CURRENT PHARMACEUTICAL DESIGN
- Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
- (2015) Wenzhe Ma et al. Scientific Reports
- P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review
- (2015) Hossam M. Abdallah et al. Journal of Advanced Research
- ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
- (2014) Young Choi et al. CURRENT PHARMACEUTICAL DESIGN
- Identification and characterization of potent CYP2D6 inhibitors in lotus leaves
- (2014) Lin-Hu Ye et al. JOURNAL OF ETHNOPHARMACOLOGY
- Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells
- (2014) LAURA RONCUZZI et al. ONCOLOGY REPORTS
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy
- (2011) Chung-Pu Wu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- The controversial role of ABC transporters in clinical oncology
- (2011) Akina Tamaki et al. Essays in Biochemistry
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype
- (2010) Anju Singh et al. MOLECULAR CANCER THERAPEUTICS
- Induction of Akt Activity by Chemotherapy Confers Acquired Resistance
- (2009) Wei-Chien Huang et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- PI3K/Akt inhibition modulates multidrug resistance and activates NF-κB in murine lymphoma cell lines
- (2008) Mariana G. García et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search